EXPLORER Total Body PET/CT Imaging for Myofascial Pain

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

June 13, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions
Myofascial Pain
Interventions
DRUG

18F-FDG

Each subject will undergo a dynamic 18F-FDG PET/CT scan (this drug is FDA approved) and a dynamic 11C-butanol PET/CT scan (this drug is under an IND) on the EXPLORER total-body PET/CT system. The two scans will be performed on the same day or within a period of up to four weeks depending on subject, imaging agent and scanner availability. Subjects will be asked to complete the HEAL questionnaires before or after their PET/CT scan on each day.

DRUG

11C-butanol

Each subject will undergo a dynamic 18F-FDG PET/CT scan (this drug is FDA approved) and a dynamic 11C-butanol PET/CT scan (this drug is under an IND) on the EXPLORER total-body PET/CT system. The two scans will be performed on the same day or within a period of up to four weeks depending on subject, imaging agent and scanner availability. Subjects will be asked to complete the HEAL questionnaires before or after their PET/CT scan on each day.

Trial Locations (1)

95826

RECRUITING

University of California Davis Health, Sacramento

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of California, Davis

OTHER